Adverts

Open Access Articles- Top Results for Org 12962

Org 12962

</th></tr>
Org 12962
240px
Systematic (IUPAC) name
1-(5-trifluoromethyl-6-chloropyridin-2-yl)piperazine
Clinical data
  • Uncontrolled
Identifiers
210821-63-9 7pxN
PubChem CID 9796408
ChemSpider 7972174 7pxY
ChEMBL CHEMBL506999 7pxY
Chemical data
Formula C10H11ClF3N3
265.662 g/mol
 14pxN (what is this?)  (verify)

Org 12962 is a drug developed by Organon, which acts as a potent and selective agonist for the 5-HT2 receptor family, with highest affinity at 5-HT2C and lowest at 5-HT2B subtypes.[1] It was developed as a potential anti-anxiety drug, but was discontinued from human trials after tests in a public speaking challenge showed that its anti-anxiety effects were accompanied by side effects such as dizziness and a "spacey" feeling, which were attributed to poor selectivity in vivo over the hallucinogenic 5-HT2A receptor.[2]

See also

References

  1. ^ Porter RH, Benwell KR, Lamb H, Malcolm CS, Allen NH, Revell DF, Adams DR, Sheardown MJ (September 1999). "Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells". British Journal of Pharmacology 128 (1): 13–20. PMC 1571597. PMID 10498829. doi:10.1038/sj.bjp.0702751. 
  2. ^ Monck NJ, Kennett GA (2008). "5-HT2C ligands: recent progress". Progress in Medicinal Chemistry 46: 281–390. PMID 18381128. doi:10.1016/S0079-6468(07)00006-9. 



Lua error in package.lua at line 80: module 'Module:Buffer' not found.